Abstract

Ductal carcinoma in situ can detected with percent of 15-20 with scanning programs. Modified Van Nuys Prognostic index is used in classification concerning age, size of tumor, margin of surgical resection, nuciear grade and necrosis. This antity has a speciai importance because it can mostly manage with breast sparing treatment modalities. But it shows significance when it combined with systemic sclerosant diseases. We report a case with scleroderma diagnosed as ductal carcinoma in situ. İn the light of our case our aim is to summarize the clinical follow-up and treatment modalities in such cases with ductal carcinoma in situ combined with systemic sclerosant diseases.